/* Product view custom css */

Martin & Harris Laboratories Ltd Unlisted Shares Transfer Only in NSDL A/C

Master

Martin & Harris Laboratories Ltd Unlisted Shares Transfer Only in NSDL A/C

Face Value 10
ISIN No INE03VV01015

You Can Buy The Below Quantity From Us By Clicking On “Buy Now” Or For More & Bulk Quantity, You Can Contact Us On: 02249369990 / 09867572101 / 09987204585
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
1010813 10 50 Rs 970.00 Rs 48,500.00 Rs Demat 25

Company Information


Martin and Harris Laboratories Limited Unlisted Shares


Board of Directors

Director

: Mr. Ashok Chandra Sen

Director

: Mr. Nasim Uddin

Director

: Mr. Harnam Thakur Singh

Director

: Mr. Vivek Manohar Padgoankar


Background

Martin & Harris Laboratories and its subsidiaries, collectively are engaged in the manufacturing of pharmaceuticals, medicinal chemical, botanical products, active pharma ingredients products and infrastructure business.


Registered Office

N.H.-8, Delhi. Jaipur Highway Village Pachgaon (Fazalwas) Distt. Gurgaon, Haryana (India).


INCORPORATION YEAR

: 1993

WEBSITE

: www.martinharrislabs.com

EMAIL

: sec@martinharrislabs.com

CIN NO

: U24239HRI993PLCO33630

ISIN NO.

: INE03VV01015

SECTOR

: Healthcare

FACE VALUE

: 10


Consolidated Financial Information for Last 3 Years (Rupees In Crore)

Particulars

2025

2024

2023

Equity Capital

4.00

4.00

4.00

Reserve & Surplus

694.97

628.07

589.29

Net worth

698.97

632.07

593.29

Book Value Per share Rs.

1747.42

1581.76

1484.70

Revenue from Operations

107.43

146.15

205.16

Other Income

43.80

34.29

24.08

Total Income

151.23

180.44

229.25

Profit*

66.30

40.43

68.07

EPS Rs.*

165.93

101.17

170.34

Note: *Profit and EPS includes Exceptional items


Annual Report of Martin and Harris Laboratories Limited Unlisted Shares

Annual Report of Martin and Harris Laboratories Limited – 2025

Annual Report of Martin and Harris Laboratories Limited – 2024

Annual Report of Martin and Harris Laboratories Limited – 2023

Cookie Consent

We use cookies to ensure you have the best browsing experience on our website. By using our site, you acknowledge that you have read and understood our Cookie Policy & Privacy